Phase 3, randomized control trial (n=24,966) for single dose RSV vaccine (RSVPreF3 OA) was shown to be highly efficacious against severe disease and infection in older adults (60+) regardless of RSV subtype - discu.eu

Reddit

Phase 3, randomized control trial (n=24,966) for single dose RSV vaccine (RSVPreF3 OA) was shown to be highly efficacious against severe disease and infection in older adults (60+) regardless of RSV subtype https://www.nejm.org/doi/full/10.1056/NEJMoa2209604 4 comments 19/2/2023 science

Linking pages

An RSV vaccine has been approved by the FDA. It’s a huge deal. - Vox https://www.vox.com/health/2023/5/4/23710959/rsv-vaccine-for-adults-arexvy-fda-approval 29 comments
FDA approves RSV vaccine for adults ages 60 and up https://www.nbcnews.com/health/health-news/fda-approves-rsv-vaccine-rcna82461 6 comments
FDA approves first RSV vaccine, a moment six decades in the making | CNN https://www.cnn.com/2023/05/03/health/first-rsv-vaccine-approved/index.html 2 comments

Related searches:

Search whole site: site:www.nejm.org

Search title: Phase 3, randomized control trial (n=24,966) for single dose RSV vaccine (RSVPreF3 OA) was shown to be highly efficacious against severe disease and infection in older adults (60+) regardless of RSV subtype

See how to search.

Submit link to: